Technical Analysis for OYST - Oyster Point Pharma, Inc.

Grade Last Price % Change Price Change
F 19.91 -2.64% -0.54
OYST closed down 2.64 percent on Monday, April 19, 2021, on 1.13 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical OYST trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Fell Below 20 DMA Bearish -2.64%
Multiple of Ten Bullish Other -2.64%
20 DMA Support Bullish -6.74%
Up 3 Days in a Row Strength -6.74%
Up 4 Days in a Row Strength -6.74%
50 DMA Resistance Bearish -6.04%
Shooting Star Candlestick Bearish -6.04%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.04%
Older End-of-Day Signals for OYST ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 16 hours ago
Down 3% about 16 hours ago
Fell Below Previous Day's Low about 16 hours ago
Down 2 % about 17 hours ago
Down 1% about 17 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its lead product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Eye Chemical Compounds Symptoms Psychoactive Drugs Eye Disease Neurochemistry Choline Nicotine Nasal Spray Cholinergics Dry Eye Disease Stimulants Acetylcholine Muscarinic Agonist Nicotinic Agonists Ocular Surface Diseases Teratogens

Is OYST a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 36.9
52 Week Low 17.24
Average Volume 77,536
200-Day Moving Average 21.87
50-Day Moving Average 21.61
20-Day Moving Average 20.62
10-Day Moving Average 20.77
Average True Range 1.34
ADX 9.51
+DI 18.14
-DI 22.09
Chandelier Exit (Long, 3 ATRs ) 19.15
Chandelier Exit (Short, 3 ATRs ) 21.59
Upper Bollinger Band 22.97
Lower Bollinger Band 18.27
Percent B (%b) 0.35
BandWidth 22.78
MACD Line -0.16
MACD Signal Line -0.19
MACD Histogram 0.0289
Fundamentals Value
Market Cap 515.04 Million
Num Shares 25.9 Million
EPS -2.16
Price-to-Earnings (P/E) Ratio -9.20
Price-to-Sales 0.00
Price-to-Book 2.69
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.94
Resistance 3 (R3) 22.04 21.47 21.60
Resistance 2 (R2) 21.47 20.95 21.42 21.49
Resistance 1 (R1) 20.69 20.63 20.40 20.59 21.38
Pivot Point 20.11 20.11 19.97 20.06 20.11
Support 1 (S1) 19.33 19.59 19.05 19.23 18.44
Support 2 (S2) 18.76 19.27 18.71 18.33
Support 3 (S3) 17.98 18.76 18.22
Support 4 (S4) 17.88